# Immunological aspects of halo nevus (Sutton’s Nevus)

**Authors:** Nika Hlača, Marijana Vičić, Larisa Prpić-Massari

PMC · DOI: 10.3389/fimmu.2026.1729726 · Frontiers in Immunology · 2026-02-04

## TL;DR

Halo nevus is a skin condition that helps researchers study how the immune system targets melanocytes, offering insights into pigment disorders and cancer.

## Contribution

The paper highlights halo nevus as a model for immune-mediated melanocyte destruction, bridging pigment disorders and tumor immunology.

## Key findings

- Halo nevus involves CD8+ T cell-mediated destruction of melanocytes.
- It shares similarities with vitiligo and regressing melanoma in immune mechanisms.
- It provides insights into immune balance and antigen triggers in melanocyte destruction.

## Abstract

Halo nevus has historically been observed as a localized skin phenomenon surrounding a melanocytic nevus. However, emerging studies indicate that halo nevus serves as a model for immune-mediated, primarily CD8+ T cells–targeted destruction of melanocytes, similar to vitiligo or regressing melanoma. The aim of this mini-review is to summarize the current understanding of the immunological mechanisms underlying halo nevus formation, to highlight similarities and differences between halo nevus and vitiligo, as well as contrasts with regressing melanoma. Acknowledging halo nevus as a model for a controlled immune response against melanocytes could offer valuable insights into understanding triggers, potential antigens, and the balance of effector and regulatory responses, with translational relevance to pigment disorders and tumor immunology.

## Linked entities

- **Diseases:** vitiligo (MONDO:0008661), melanoma (MONDO:0005105)

## Full-text entities

- **Genes:** IL10 (Interleukin 10 level) [NCBI Gene 103158318], IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, FOXP3 (forkhead box P3) [NCBI Gene 444998], CXCL9 (C-X-C motif chemokine ligand 9) [NCBI Gene 4283] {aka CMK, Humig, MIG, SCYB9, crg-10}, F13A1 (coagulation factor XIII A chain) [NCBI Gene 2162] {aka F13A}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, IL10 (interleukin 10) [NCBI Gene 397106] {aka CSIF, IL-10}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CR2 (complement C3d receptor 2) [NCBI Gene 1380] {aka C3DR, CD21, CR, CVID7, SLEB9}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, IFNG (interferon gamma) [NCBI Gene 396991], GNLY (granulysin) [NCBI Gene 10578] {aka D2S69E, LAG-2, LAG2, NKG5, TLA519}, FASLG (Fas ligand) [NCBI Gene 356] {aka ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD274 (CD274 molecule) [NCBI Gene 574058] {aka PDL1}, PDCD1 (programmed cell death 1) [NCBI Gene 100533201], FASLG (Fas ligand) [NCBI Gene 396726] {aka CD95-L, FASL, TNFSF6}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}
- **Diseases:** pernicious anemia (MESH:D000752), Hashimoto disease (MESH:D050031), blue nevi (MESH:D018329), autoimmune (MESH:D001327), immune-mediated (MESH:C567355), malignant tumor (MESH:D009369), vitiligo (MESH:D014820), pigment disorders (MESH:D010859), melanocytic lesion (MESH:D009508), inflammation (MESH:D007249), fibrosis (MESH:D005355), Melanoma (MESH:D008545), systemic autoimmune diseases (MESH:D020274), Sutton's Nevus (MESH:C538145), depigmented skin lesions (MESH:D012871), hypopigmentation (MESH:D017496), Halo nevi (MESH:D055882), basal cell carcinoma (MESH:D002280), alopecia areata (MESH:D000506), halo naevus (MESH:C580062), Nevus (MESH:D009506), infections (MESH:D007239), cytotoxic (MESH:D064420), seborrhoeic keratoses (MESH:D007642), dermatofibromas (MESH:D018219), Spitz nevi (MESH:D018332)
- **Chemicals:** lipid (MESH:D008055), UDP-G (MESH:D014532), BioRender (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913448/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12913448/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913448/full.md

---
Source: https://tomesphere.com/paper/PMC12913448